Blair William & CO Bio N Tech Se Transaction History

Blair William & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$127.65 - $183.11 $7,276 - $10,437	-57 Reduced 2.81%	1,973 $266,000
Q2 2022 Aug 10, 2022	BUY	$123.25 - $186.24 $5,916 - $8,939	48 Added 2.42%	2,030 $303,000
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $10,605 - $19,475	-84 Reduced 4.07%	1,982 $338,000
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $122,184 - $204,461	-564 Reduced 21.44%	2,066 $533,000
Q2 2021 Aug 12, 2021	BUY	$113.32 - $241.49 $2,379 - $5,071	21 Added 0.8%	2,630 $589,000
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $223,669 - $311,775	2,609 New	2,609 $285,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.